(95% CI 1.003-1.030). Glycemic control, macrosomia, shoulder dystocia and hyperbilirubinemia did not differ between groups. Odds of neonatal hypoglycemia doubled with increased distance from PNC (Table) . Per mile over 30 miles, the odds increased 1% (95% CI 1.004-1.021). CONCLUSION: Traveling further for prenatal care was associated with increased odds of cesarean and neonatal hypoglycemia, in spite of no detectable differences in glycemic control. When access to care and maternal morbidity are explored, distance from site of care should be considered as a contributing factor to patient and public health outcomes. OBJECTIVE: In November 2017 American College of Cardiology (ACC) and American Heart Association (AHA) published new guidelines which lower the cut-off for hypertension. There has been no study that evaluate the cost-benefit of expanding the eligibility of aspirin with a lower cut-off for the definition of chronic hypertension. Our objective in this study was to develop a decision model to evaluate the impact of new ACC/AHA hypertension guidelines to the risks, benefits and costs of several low-dose aspirin prophylaxis approaches for preeclampsia prevention. STUDY DESIGN: We created a decision tree analysis to evaluate four approaches to aspirin prophylaxis in the United States: no aspirin, USPSTF with old ACC/AHA hypertension guidelines, USPSTF with new ACC/AHA hypertension guidelines as well as universal aspirin prophylaxis. To build this model PubMed literature review was performed to find a range for various clinical parameters pertinent to the model. We accounted for cost of aspirin, cost of medication side effects, adverse events and hypersensitivity reaction. Benefits were derived from aspirin-related obstetrical complications risks reduction, including preeclampsia, preterm birth as well as perinatal and neonatal death. This model was executed to simulate a hypothetical cohort of 4 million pregnant women in the United States.
OBJECTIVE:
In November 2017 American College of Cardiology (ACC) and American Heart Association (AHA) published new guidelines which lower the cut-off for hypertension. There has been no study that evaluate the cost-benefit of expanding the eligibility of aspirin with a lower cut-off for the definition of chronic hypertension. Our objective in this study was to develop a decision model to evaluate the impact of new ACC/AHA hypertension guidelines to the risks, benefits and costs of several low-dose aspirin prophylaxis approaches for preeclampsia prevention. STUDY DESIGN: We created a decision tree analysis to evaluate four approaches to aspirin prophylaxis in the United States: no aspirin, USPSTF with old ACC/AHA hypertension guidelines, USPSTF with new ACC/AHA hypertension guidelines as well as universal aspirin prophylaxis. To build this model PubMed literature review was performed to find a range for various clinical parameters pertinent to the model. We accounted for cost of aspirin, cost of medication side effects, adverse events and hypersensitivity reaction. Benefits were derived from aspirin-related obstetrical complications risks reduction, including preeclampsia, preterm birth as well as perinatal and neonatal death. This model was executed to simulate a hypothetical cohort of 4 million pregnant women in the United States.
RESULTS:
Based on our simulation model, the new hypertension guidelines would expand the aspirin eligibility by 8% (76,953 women) in the USPSTF guidelines. We also showed that even with this increased eligibility, USPSTF guidelines continues to be the approach with the most cost savings ($386.5 million) when compared to no aspirin and universal aspirin approaches ($373.2 million). The new hypertension guidelines are projected to increase the cost savings of the USPSTF approach by $9.4 million. CONCLUSION: The increased prevalence of chronic hypertension due to the change in hypertension cut-off is expected to increase the eligibility of aspirin prophylaxis for preeclampsia by 8%. Despite the small change in aspirin prophylaxis, it still results in an annual costsaving of $9.4 million in the United States.
Preconception uninsurance: associations with prenatal care and pregnancy outcomes
Mark A. Clapp, Kaitlyn E. James, Anjali J. Kaimal Massachusetts General Hospital, Boston, MA OBJECTIVE: Health insurance has been associated with increased use of preventative care and screening services. The primary objective of this study was to determine the association between uninsurance and the initiation of prenatal care. Secondarily, the relationship between preconception uninsurance and birth outcomes were examined. STUDY DESIGN: This study is a retrospective analysis of women participating in the Pregnancy Risk Assessment Monitoring System between 2009 and 2013, prior to the implementation of the major provisions of the Affordable Care Act. Self-reported insurance status in the 30 days prior to pregnancy was used to define the primary exposure. The primary outcome was first trimester initiation of prenatal care. Secondary outcomes included: preterm delivery among nulliparous patients, small for gestational age (<10%), large for gestational age (>90%), neonatal intensive care unit admission among term, non-anomalous infants, and the presence of birth defects. Survey-weighted generalized linear models were used to calculate risk ratios for the outcomes. Multivariate models adjusted for patient age, race, ethnicity, education, marital status, and average family income. Robust standard errors were used to account for state-level clustering. RESULTS: 181,675 women from 32 states were included. The overall uninsurance rate prior to conception was 21.1%. 88% of women with insurance compared to 70% of women without insurance initiated prenatal care in the first trimester. Prevalence of secondary outcomes are shown in Table 1 . The risk ratios for the outcomes are listed in Table 2 . After controlling for demographic variables, uninsurance was associated with a 14% increased risk of not Poster Session IV 
